[HTML][HTML] IGH@ translocations co-exist with other primary rearrangements in B-cell precursor acute lymphoblastic leukemia
SJ Jeffries, L Jones, CJ Harrison, LJ Russell - Haematologica, 2014 - ncbi.nlm.nih.gov
Primary established genetic abnormalities in B-cell precursor acute lymphoblastic leukemia
include high hyperdiploidy (51–65 chromosomes), the translocations t (12; 21)(p13; …
include high hyperdiploidy (51–65 chromosomes), the translocations t (12; 21)(p13; …
[HTML][HTML] Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries
C Lundin, E Forestier, M Klarskov Andersen… - Journal of hematology & …, 2014 - Springer
Abstract Background Children with Down syndrome (DS) have an increased risk for acute
lymphoblastic leukemia (ALL). Although previous studies have shown that DS-ALL differs …
lymphoblastic leukemia (ALL). Although previous studies have shown that DS-ALL differs …
Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies
Over the past decade, there has been increasing biochemical evidence that the Janus
kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is aberrantly …
kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is aberrantly …
Gene alterations involving the CRLF2‐JAK pathway and recurrent gene deletions in D own syndrome‐associated acute lymphoblastic leukemia in Japan
I Hanada, K Terui, F Ikeda, T Toki… - Genes …, 2014 - Wiley Online Library
In Western countries, gene alterations involving the CRLF2‐JAK signaling pathway are
identified in approximately 50–60% of patients with Down syndrome‐associated acute …
identified in approximately 50–60% of patients with Down syndrome‐associated acute …
[HTML][HTML] RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells
L Fu, S Zhang - International journal of molecular …, 2014 - spandidos-publications.com
As the most lethal gynecological malignancy, ovarian cancer has attracted much attention
over the past few decades; however, the early detection of this malignancy has been largely …
over the past few decades; however, the early detection of this malignancy has been largely …
IGF2BP1: a novel IGH translocation partner in B acute lymphoblastic leukemia
G Gu, MC Sederberg, MR Drachenberg, ST South - Cancer genetics, 2014 - Elsevier
Acute lymphoblastic leukemia (ALL) is the most common form of childhood malignancy.
Detecting and characterizing recurrent translocations is critical for ALL diagnosis and …
Detecting and characterizing recurrent translocations is critical for ALL diagnosis and …
Towards precision medicine in childhood leukemia–insights from mutationally activated cytokine receptor pathways in acute lymphoblastic leukemia
S Izraeli, C Shochat, N Tal, I Geron - Cancer letters, 2014 - Elsevier
The successful therapy of childhood leukemia has been characterized by careful
personalized adaptation of therapy by risk stratification. Yet almost all drugs are relatively …
personalized adaptation of therapy by risk stratification. Yet almost all drugs are relatively …
IL-7 and TSLP receptors: twisted sisters
SK Durum - Blood, The Journal of the American Society of …, 2014 - ashpublications.org
IL-7, produced by stromal cells in the thymus and other lymphoid organs, is required for
thymic development and peripheral survival of T cells. The IL-7 receptor (IL-7R) consists of 2 …
thymic development and peripheral survival of T cells. The IL-7 receptor (IL-7R) consists of 2 …
[HTML][HTML] Emerging therapeutic paradigms to target the dysregulated JAK/STAT pathways in hematological malignancies
Over the past decade, there has been increasing biochemical evidence that the Janus
kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is aberrantly …
kinase (JAK)-signal transducer and activator of transcription (STAT) pathway is aberrantly …
[HTML][HTML] Loss of chromosome Y in acute lymphoblastic leukemia: Age related or neoplastic phenomenon?
Loss of chromosome Y (LOY) in the bone marrow has long been considered as an age-
related phenomenon with an incidence of more than 25% in males beyond the age of 80 …
related phenomenon with an incidence of more than 25% in males beyond the age of 80 …